
Bilastine
CAS No. 202189-78-4
Bilastine( Bilastine trade name Bilaxten )
Catalog No. M18206 CAS No. 202189-78-4
Bilastine is a novel new-generation antihistamine that is highly selective for the H1 histamine receptor, has a rapid onset and prolonged duration of action.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
25MG | 35 | In Stock |
![]() ![]() |
50MG | 58 | In Stock |
![]() ![]() |
100MG | 95 | In Stock |
![]() ![]() |
200MG | 140 | In Stock |
![]() ![]() |
500MG | 236 | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameBilastine
-
NoteResearch use only, not for human use.
-
Brief DescriptionBilastine is a novel new-generation antihistamine that is highly selective for the H1 histamine receptor, has a rapid onset and prolonged duration of action.
-
DescriptionBilastine (trade name Bilaxten) is a second generation antihistamine drug for the treatment of allergic rhinoconjunctivitis and urticaria (hives). It exerts its effect as a selective histamine H1 receptor antagonist, and has a potency similar to cetirizine and is superior to fexofenadine. It was developed in Spain by FAES Farma. Bilastine is approved in the European Union for the symptomatic treatment of allergic rhinoconjunctivitis and urticaria, but it is not approved by the U.S. Food and Drug Administration for any use in the United States. Bilastine has been effective in the treatment of ocular symptoms and diseases of allergies, including rhinoconjuctivitis. Additionally, bilastine has been shown to improve quality of life, and all nasal and ocular symptoms related to allergic rhinitis.
-
In Vitro——
-
In Vivo——
-
SynonymsBilastine trade name Bilaxten
-
PathwayEndocrinology/Hormones
-
Target5-HT Receptor
-
RecptorH1 receptor
-
Research AreaInflammation/Immunology
-
Indication——
Chemical Information
-
CAS Number202189-78-4
-
Formula Weight463.62
-
Molecular FormulaC28H37N3O3
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 49.3 mg/mL; 106.34 mM
-
SMILESCCOCCn1c(nc2ccccc12)C1CCN(CCc2ccc(cc2)C(C)(C)C(O)=O)CC1
-
Chemical Name2-(4-(2-(4-(1-(2-ethoxyethyl)-1H-benzo[d]imidazol-2-yl)piperidin-1-yl)ethyl)phenyl)-2-methylpropanoic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Wolthers OD.Bilastine: a new nonsedating oral H1 antihistamine for treatment of allergic rhinoconjunctivitis and urticaria.Biomed Res Int. 2013;2013:626837.
molnova catalog



related products
-
XEN-445
XEN445, a potent and selective endothelial lipase(EL) inhibitor (IC50=0.237 uM), exhibitis good ADME and PK properties.
-
Dehydroaripiprazole
Dehydroaripiprazole is the active metabolite of aripiprazole. Aripiprazole is an antipsychotic drug, which is metabolized by CYP3A4 and CYP2D6 and mainly forms dehydroaripiprazole.
-
Peptide 401
Peptide 401 is an antimicrobial peptide (AMP) derived from the venom of bees and wasps. Peptide 401 induces mast cell degranulation, activating histamine release from peritoneal mast cells. Additionally, peptide 401 exhibits some anti-inflammatory activity, decreasing paw edema in animal models.